Work

Lenvatinib May Drastically Change the Treatment Landscape of Hepatocellular Carcinoma

Year: 2018
Type: article
Abstract: in intermediate-stage HCC, a real cure for HCC may cease to be a dream.In fact, clinical trials of combination therapy with lenvatinib and pembrolizumab for HCC have already started (Fig. 9), leaving little doubt that the landscape of HCC treatment will undergo drastic changes in years to come.
Source: Liver Cancer
Language: English
Subfield: Hepatology
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,590
OpenAlex ID: W2789297669
FWCI: 8.512
Cites: 62
Cited by: 144
Related to: 10